Farmakoekonomska evaluacija fakoemulzifikacije i ekstrakapsularne ekstrakcije u operaciji katarakte

  • Katarina Radujević University of Belgrade, Faculty of Pharmacy, Department of Social Pharmacy and Pharmacy Legislation
  • Nataša Bogavac Stanojević University of Belgrade, Faculty of Pharmacy, Department of Medical Biochemistry
  • Rade Nedeljković General Hospital Kruševac
  • Dragana Lakić University of Belgrade, Faculty of Pharmacy, Department of Social Pharmacy and Pharmacy Legislation
Ključne reči: katarakta;, troškovi-korist, analiza;, hirurgija, oftalmološka, procedure;, fakoemulzifikacija;, farmakoekonomika;, srbija

Sažetak


Uvod/Cilj. Operacija katarakte predstavlja jednu od najčešće primenjivanih hirurških intervencija. U zapadnim zemljama, dominantna tehnika je fakoemulzifikacija, dok je u zemljama u razvoju najzastupljenija tehnika ekstrakapsularne ekstrakcije (ECCE). Cilj rada bio je da se proceni ekonomska isplativost te dve tehnike operacije katarakte iz perspektive pružaoca usluge, ukoliko se kao ishod posmatraju komplikacije. Metode. Podaci su dobijeni sa Očnog odeljenja Opšte bolnice Kruševac tokom jednogodišnjeg perioda. Ukupno je izvedeno 1 179 operacija od strane pet hirurga. Ekonomska isplativost je procenjena primenom „drveta odlučivanja“. Verovatnoće za događaje su izračunate na osnovu verovatnoće pojavljivanja tokom navedenog perioda. U analizi su razmatrani samo direktni troškovi, a vrednosti su preuzete iz prateće dokumentacije i zvaničnog cenovnika zdravstvenih usluga. Sprovedena je jednosmerna i dvosmerna analiza osetljivosti. Rezultati. Ukupni troškovi u grupi koja je bila podvrgnuta fakoemulzifikaciji iznosili su  71 008.70 srpskih dinara (RSD), dok su u ECCE grupi oni iznosili 74 340.36 RSD. Istovremeno, fakoemulzifikacija je pokazala višu efikasnost u odnosu na ECCE, 87% i 57% bolesnika bez komplikacija, redom. Na osnovu dobijenih rezultata, fakoemulzifikacija je bila dominantna strategija u poređenju sa ECCE. Analiza osetljivosti pokazala je da su rezultati osetljivi na broj izvršenih intervencija na godišnjem nivou. Zaključak. Fakoemulzifikacija je ekonomski isplativija tehnika operacije katarakte u odnosu na ECCE. Sva ulaganje u opremu i potrošni materijal za fakoemulzifikaciju opravdani su ukoliko je broj izvedenih operacija na godišnjem nivou preko 350.

Biografije autora

Nataša Bogavac Stanojević, University of Belgrade, Faculty of Pharmacy, Department of Medical Biochemistry

Katedra za medicinsku biohemiju

Dragana Lakić, University of Belgrade, Faculty of Pharmacy, Department of Social Pharmacy and Pharmacy Legislation

Katedra za socijalnu farmaciju i farmaceutsko zakonodavstvo

Reference

800x600

Normal

0

false

false

false

EN-US

X-NONE

X-NONE

MicrosoftInternetExplorer4

DefSemiHidden="false" DefQFormat="false" DefPriority="99"

LatentStyleCount="371">

UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>

UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>

Name="index 1"/>

Name="index 2"/>

Name="index 3"/>

Name="index 4"/>

Name="index 5"/>

Name="index 6"/>

Name="index 7"/>

Name="index 8"/>

Name="index 9"/>

UnhideWhenUsed="true" Name="toc 1"/>

UnhideWhenUsed="true" Name="toc 2"/>

UnhideWhenUsed="true" Name="toc 3"/>

UnhideWhenUsed="true" Name="toc 4"/>

UnhideWhenUsed="true" Name="toc 5"/>

UnhideWhenUsed="true" Name="toc 6"/>

UnhideWhenUsed="true" Name="toc 7"/>

UnhideWhenUsed="true" Name="toc 8"/>

UnhideWhenUsed="true" Name="toc 9"/>

Name="Normal Indent"/>

Name="footnote text"/>

Name="annotation text"/>

Name="header"/>

Name="footer"/>

Name="index heading"/>

UnhideWhenUsed="true" QFormat="true" Name="caption"/>

Name="table of figures"/>

Name="envelope address"/>

Name="envelope return"/>

Name="footnote reference"/>

Name="annotation reference"/>

Name="line number"/>

Name="page number"/>

Name="endnote reference"/>

Name="endnote text"/>

Name="table of authorities"/>

Name="macro"/>

Name="toa heading"/>

Name="List"/>

Name="List Bullet"/>

Name="List Number"/>

Name="List 2"/>

Name="List 3"/>

Name="List 4"/>

Name="List 5"/>

Name="List Bullet 2"/>

Name="List Bullet 3"/>

Name="List Bullet 4"/>

Name="List Bullet 5"/>

Name="List Number 2"/>

Name="List Number 3"/>

Name="List Number 4"/>

Name="List Number 5"/>

Name="Closing"/>

Name="Signature"/>

UnhideWhenUsed="true" Name="Default Paragraph Font"/>

Name="Body Text"/>

Name="Body Text Indent"/>

Name="List Continue"/>

Name="List Continue 2"/>

Name="List Continue 3"/>

Name="List Continue 4"/>

Name="List Continue 5"/>

Name="Message Header"/>

Name="Salutation"/>

Name="Date"/>

Name="Body Text First Indent"/>

Name="Body Text First Indent 2"/>

Name="Note Heading"/>

Name="Body Text 2"/>

Name="Body Text 3"/>

Name="Body Text Indent 2"/>

Name="Body Text Indent 3"/>

Name="Block Text"/>

Name="Hyperlink"/>

Name="FollowedHyperlink"/>

Name="Document Map"/>

Name="Plain Text"/>

Name="E-mail Signature"/>

Name="HTML Top of Form"/>

Name="HTML Bottom of Form"/>

Name="Normal (Web)"/>

Name="HTML Acronym"/>

Name="HTML Address"/>

Name="HTML Cite"/>

Name="HTML Code"/>

Name="HTML Definition"/>

Name="HTML Keyboard"/>

Name="HTML Preformatted"/>

Name="HTML Sample"/>

Name="HTML Typewriter"/>

Name="HTML Variable"/>

Name="Normal Table"/>

Name="annotation subject"/>

Name="No List"/>

Name="Outline List 1"/>

Name="Outline List 2"/>

Name="Outline List 3"/>

Name="Table Simple 1"/>

Name="Table Simple 2"/>

Name="Table Simple 3"/>

Name="Table Classic 1"/>

Name="Table Classic 2"/>

Name="Table Classic 3"/>

Name="Table Classic 4"/>

Name="Table Colorful 1"/>

Name="Table Colorful 2"/>

Name="Table Colorful 3"/>

Name="Table Columns 1"/>

Name="Table Columns 2"/>

Name="Table Columns 3"/>

Name="Table Columns 4"/>

Name="Table Columns 5"/>

Name="Table Grid 1"/>

Name="Table Grid 2"/>

Name="Table Grid 3"/>

Name="Table Grid 4"/>

Name="Table Grid 5"/>

Name="Table Grid 6"/>

Name="Table Grid 7"/>

Name="Table Grid 8"/>

Name="Table List 1"/>

Name="Table List 2"/>

Name="Table List 3"/>

Name="Table List 4"/>

Name="Table List 5"/>

Name="Table List 6"/>

Name="Table List 7"/>

Name="Table List 8"/>

Name="Table 3D effects 1"/>

Name="Table 3D effects 2"/>

Name="Table 3D effects 3"/>

Name="Table Contemporary"/>

Name="Table Elegant"/>

Name="Table Professional"/>

Name="Table Subtle 1"/>

Name="Table Subtle 2"/>

Name="Table Web 1"/>

Name="Table Web 2"/>

Name="Table Web 3"/>

Name="Balloon Text"/>

Name="Table Theme"/>

Name="List Paragraph"/>

Name="Intense Quote"/>

Name="Subtle Emphasis"/>

Name="Intense Emphasis"/>

Name="Subtle Reference"/>

Name="Intense Reference"/>

UnhideWhenUsed="true" Name="Bibliography"/>

UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>

Name="Grid Table 1 Light Accent 1"/>

Name="Grid Table 6 Colorful Accent 1"/>

Name="Grid Table 7 Colorful Accent 1"/>

Name="Grid Table 1 Light Accent 2"/>

Name="Grid Table 6 Colorful Accent 2"/>

Name="Grid Table 7 Colorful Accent 2"/>

Name="Grid Table 1 Light Accent 3"/>

Name="Grid Table 6 Colorful Accent 3"/>

Name="Grid Table 7 Colorful Accent 3"/>

Name="Grid Table 1 Light Accent 4"/>

Name="Grid Table 6 Colorful Accent 4"/>

Name="Grid Table 7 Colorful Accent 4"/>

Name="Grid Table 1 Light Accent 5"/>

Name="Grid Table 6 Colorful Accent 5"/>

Name="Grid Table 7 Colorful Accent 5"/>

Name="Grid Table 1 Light Accent 6"/>

Name="Grid Table 6 Colorful Accent 6"/>

Name="Grid Table 7 Colorful Accent 6"/>

Name="List Table 1 Light Accent 1"/>

Name="List Table 6 Colorful Accent 1"/>

Name="List Table 7 Colorful Accent 1"/>

Name="List Table 1 Light Accent 2"/>

Name="List Table 6 Colorful Accent 2"/>

Name="List Table 7 Colorful Accent 2"/>

Name="List Table 1 Light Accent 3"/>

Name="List Table 6 Colorful Accent 3"/>

Name="List Table 7 Colorful Accent 3"/>

Name="List Table 1 Light Accent 4"/>

Name="List Table 6 Colorful Accent 4"/>

Name="List Table 7 Colorful Accent 4"/>

Name="List Table 1 Light Accent 5"/>

Name="List Table 6 Colorful Accent 5"/>

Name="List Table 7 Colorful Accent 5"/>

Name="List Table 1 Light Accent 6"/>

Name="List Table 6 Colorful Accent 6"/>

Name="List Table 7 Colorful Accent 6"/>

/* Style Definitions */

table.MsoNormalTable

{mso-style-name:"Table Normal";

mso-tstyle-rowband-size:0;

mso-tstyle-colband-size:0;

mso-style-noshow:yes;

mso-style-priority:99;

mso-style-parent:"";

mso-padding-alt:0cm 5.4pt 0cm 5.4pt;

mso-para-margin:0cm;

mso-para-margin-bottom:.0001pt;

mso-pagination:widow-orphan;

font-size:10.0pt;

font-family:"Times New Roman",serif;}

1.      Nikolić Lj. Cataract surgery. 1st ed. Belgrade: Zavod za udžbenike; 2009. (Serbian)

2.      WHO. Blindness and vision impairment. Available from: https://www.who.int/en/news-room/fact-sheets/detail/blind
/>ness-and-visual-impairment  [accessed 2021 April 21].

3.      National Eye Institute. Cataract Data and Statistics. Available from: https://www.nei.nih.gov/learn-about-eye-health/resour
/>ces-for-health-educators/eye-health-data-and-statistics/catarac
t-data-and-statistics [accessed 2021 April 21].

4.      Prokofyeva E, Wegener A, Zrenner E. Cataract prevalence and prevention in Europe: a literature review. Acta Ophthalmol 2013; 91(5): 395‒405.

5.      Hugosson M, Ekström C. Prevalence and risk factors for age-related cataract in Sweden. Ups J Med Sci 2020; 125(4): 311‒5.

6.      Institute of Public Health "Dr. Milan Jovanovic Batut". Selected health indicators for 2017. Belgrade: Institute of Public Health “Dr. Milan Jovanovic Batut”; 2018. (Serbian)

7.      American Academy of Ophthalmology. Cataract in the Adult Eye Preferred Practice Pattern 2016. San Francisco, CA: American Academy of Ophthalmology; 2016.

8.      Manaf MRA, Aljunid SM, Annuar FH, Leong CK, Mansor N. Cost-effectiveness analysis of cataract surgery with intraocular lens implantation: extracapsular cataract extraction versus phacoemulsification. Med J Indones 2007; 16(1): 25‒31.

9.      Assia-Pacific Association of Cataract & Refractive Surgeons (APACRS). Principles of Preferred Practice in Cataract Surgery. Available from: https://apacrs.org/ppp_cataract_EN
/>/index.html#6

10.   Republic Health Insurance Fund. Rulebook on prices of health services at the secondary and tertiary level. ("Sl. glasnik RS", br. 55/2019). (Serbian)

11.   Thevi T, Reddy SC, Shantakumar C. Outcome of phacoemulsification and extracapsular cataract extraction: A study in a district hospital in Malaysia. Malays Farm Physician 2014; 9(2): 41‒7.

12.   Clark A, Morlet N, Ng JQ, Preen DB, Semmens JB. Whole population trends in cataract surgery over 22 years in Western Australia. Ophthalmology 2011; 118(6): 1055–60.

13.   Kara N Jr, Sirtoli MG, Santhiago MR, Parede TR, Espíndola RF, Carvalho Rde S. Phacoemulsification versus extracapsular extraction: governmental costs. Clinics (Sao Paulo) 2010; 65(4): 357‒61.

14.   Rochmah TN, Wulandari A, Dahlui M, Ernawaty, Wulandari RD. Cost Effectiveness Analysis Using Disability-Adjusted Life Years for Cataract Surgery. Int J Environ Res Public Health 2020; 17(16): 6010.

15.   Muralikrishnan R, Venkatesh R, Prajna NV, Frick KD. Economic cost of cataract surgery procedures in an established eye care centre in Southern India. Ophthalmic Epidemiol 2004; 11(5): 369‒80.

16.   Agarwal A. Measuring the cost-effectiveness of cataract surgery. Available from: https://www.healio.com/news/ophthal
/>mology/20120325/measuring-the-cost-effectiveness-of-cataract-surgery [accessed 2022 February 03].

17.   Asimakis P, Coster DJ, Lewis DJ. Cost effectiveness of cataract surgery. A comparison of conventional extracapsular surgery and phacoemulsification at Flinders Medical Centre. Aust N Z J Ophthalmol 1996; 24(4): 319‒25.

18.   Loo CY, Kandiah M, Arumugam G, Goh PP, John E, Gurusami B, et al. Cost efficiency and cost effectiveness of cataract surgery at the Malaysian Ministry of Health ophthalmic services. Int Ophthalmol 2004; 25(2): 81‒7.

19.   de Silva SR, Riaz Y, Evans JR. Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract. Cochrane Database Syst Rev 2014; (1): CD008812.

20.   Griffiths UK, Bozzani FM, Gheorghe A, Mwenge L, Gilbert C. Cost-effectiveness of eye care services in Zambia. Cost Eff Resour Alloc 2014; 12: 6.

21.   Agarwal A, Kumar DA. Cost-effectiveness of cataract surgery. Curr Opin Ophthalmol 2011; 22(1): 15‒8.

22.   Eye Care Comparative Effectiveness Research Team (ECCERT). Hiratsuka Y, Yamada M, Akune Y, Murakami A, Okada AA, Yamashita H, et al. Cost-utility analysis of cataract surgery in Japan: a probabilistic Markov modeling study. Jpn J Ophthalmol 2013; 57(4): 391‒401.

23.   Lansingh VC, Carter MJ, Martens M. Global cost-effectiveness of cataract surgery. Ophthalmology 2007; 114(9): 1670‒8.

24.   Baltussen R, Sylla M, Mariotti SP. Cost-effectiveness analysis of cataract surgery: a global and regional analysis. Bull World Health Organ 2004; 82(5): 338‒45.

25.   Nowak MS, Grabska-Liberek I, Michalska-Małecka K, Grzybowski A, Kozioł M, Niemczyk W, et al. Incidence and Characteristics of Cataract Surgery in Poland, during 2010-2015. Int J Environ Res Public Health 2018; 15(3): 435.

26.   Randleman JB, Wolfe JD, Woodward M, Lynn MJ, Cherwek DH, Srivastava SK. The Resident Surgeon Phacoemulsification Learning Curve. Arch Ophthalmol 2007; 125(9): 1215‒9.

Objavljeno
2023/02/13
Rubrika
Originalni članak